262 related articles for article (PubMed ID: 3403089)
41. Clinical studies of aztreonam in Japan.
Hara K; Kobayashi H; Nishiura T; Yura J; Saito A
Rev Infect Dis; 1985; 7 Suppl 4():S810-24. PubMed ID: 3909341
[TBL] [Abstract][Full Text] [Related]
42. [Aztreonam: monocenter microbiological study with prevention experience in surgery].
Malcangi A; Pesce S; Vitale M; Martinetto P
G Batteriol Virol Immunol; 1987; 80(1-12):237-51. PubMed ID: 3509031
[TBL] [Abstract][Full Text] [Related]
43. [Infection caused by gram-positive and gram-negative bacteria. A comparative study].
Ruhnke-Trautmann M; Trautmann M; Brückner O; Weinke T; Wagner J
Fortschr Med; 1989 Jul; 107(22):477-80. PubMed ID: 2793023
[TBL] [Abstract][Full Text] [Related]
44. Aztreonam versus cefamandole in the treatment of urinary tract infections.
Giamarellou H; Koratzanis G; Kanellakopoulou K; Galanakis N; Papoulias G; el Messidi M; Daikos G
Chemioterapia; 1984 Apr; 3(2):127-31. PubMed ID: 6543431
[TBL] [Abstract][Full Text] [Related]
45. [Aztreonam in infections caused by gram-negative aerobic bacilli].
Rodríguez French A; Kenion G; Rodríguez C
Rev Med Panama; 1988 Jan; 13(1):4-8. PubMed ID: 3347772
[No Abstract] [Full Text] [Related]
46. Aztreonam for severe infections.
Wood MJ; Smith G; Farrell ID
Chemioterapia; 1987 Jun; 6(2 Suppl):384-5. PubMed ID: 3509453
[No Abstract] [Full Text] [Related]
47. [An Italian multicenter study on the efficacy and tolerability of aztreonam in the treatment of urinary tract infections].
Martelli A; Cortecchia V; Ventriglia L
Clin Ter; 1988 May; 125(3):191-201. PubMed ID: 2973940
[No Abstract] [Full Text] [Related]
48. [Prophylaxis in prostatic surgery with aztreonam. Our experience].
Moyano Calvo JL; Arellano Gañán R; Sempere Gutiérrez A; Sanz Sacristán J; Teba del Pino F; Melón Rey FJ; Herrero Torres L; Pereira Sanz I
Arch Esp Urol; 1992; 45(6):519-21. PubMed ID: 1510489
[TBL] [Abstract][Full Text] [Related]
49. [Teichoplanin: a clinical study of treatment of serious infections in hospitalized patients].
Di Rosa R; Maira S; Guido F; Cossu MF; Amoroso A
Riv Eur Sci Med Farmacol; 1995; 17(6):231-5. PubMed ID: 8766478
[TBL] [Abstract][Full Text] [Related]
50. [Aztreonam in the treatment of nosocomial urinary infections].
Nardini A; Taddei P; Rossi F
G Ital Chemioter; 1986; 33(2-3):139-42. PubMed ID: 3678719
[No Abstract] [Full Text] [Related]
51. Efficacy and safety of aztreonam in the treatment of patients with renal failure.
Sion ML; Pyrpasopoulos M; Nicolaidis P; Papagianni C; Tsurutsoglu G
Rev Infect Dis; 1991; 13 Suppl 7():S652-4. PubMed ID: 2068477
[TBL] [Abstract][Full Text] [Related]
52. [Aztreonam in severe gram-negative infections in hospitalized patients. Clinical experience in Spain. Preliminary data].
García-Rodríguez JA; Rabinad E
Med Clin (Barc); 1987 Apr; 88(13):538-43. PubMed ID: 3586736
[No Abstract] [Full Text] [Related]
53. Clinical experience with aztreonam in Europe: a summary of studies in Belgium, England, Finland, Ireland, the Netherlands, Norway, Portugal, and Sweden.
Norrby SR
Rev Infect Dis; 1985; 7 Suppl 4():S836-9. PubMed ID: 2934788
[TBL] [Abstract][Full Text] [Related]
54. Aztreonam, a new monobactam antimicrobial.
Guay DR; Koskoletos C
Clin Pharm; 1985; 4(5):516-26. PubMed ID: 3902330
[TBL] [Abstract][Full Text] [Related]
55. Aztreonam in treatment of intra-abdominal infections.
Malangoni MA
Urology; 1988 Jun; 31(6 Suppl):28-32. PubMed ID: 3287747
[TBL] [Abstract][Full Text] [Related]
56. Aztreonam therapy for serious gram-negative infections in children.
Stutman HR; Chartrand SA; Tolentino T; Friedhoff L; Marks MI
Am J Dis Child; 1986 Nov; 140(11):1147-51. PubMed ID: 3766490
[TBL] [Abstract][Full Text] [Related]
57. Aztreonam therapy for serious gram-negative bacillary infections.
Cone LA; Woodard DR
Rev Infect Dis; 1985; 7 Suppl 4():S794-802. PubMed ID: 3909339
[TBL] [Abstract][Full Text] [Related]
58. Successful response of severe neonatal gram-negative infection to treatment with aztreonam.
Constantopoulos A; Thomaidou L; Loupa H; Papoulias G
Chemotherapy; 1989; 35 Suppl 1():101-5. PubMed ID: 2731446
[TBL] [Abstract][Full Text] [Related]
59. Aztreonam: worldwide overview of the treatment of patients with gram-negative infections.
Henry SA; Bendush CB
Am J Med; 1985 Feb; 78(2A):57-64. PubMed ID: 3881950
[TBL] [Abstract][Full Text] [Related]
60. The clinical use of aztreonam.
Schönwald S; Schoss-Vidensek Z; Car V; Krznar B
Chemotherapy; 1989; 35 Suppl 1():45-8. PubMed ID: 2731450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
